SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-050166
Filing Date
2023-09-20
Accepted
2023-09-20 16:44:10
Documents
2
Period of Report
2023-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1537
2 POA DOCUMENT poa.txt EX-24 2940
  Complete submission text file 0001209191-23-050166.txt   5922
Mailing Address C/O ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
SMITH IAN F (Reporting) CIK: 0001197032 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 231266938

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations